Forgotten but not gone: The rediscovery of fatty heart, the most common unrecognized disease in America

Lidia S. Szczepaniak, Ronald G. Victor, Lelio Orci, Roger H Unger

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

Until 60 years ago, fatty heart was an accepted clinical entity. Since then, its very existence has been questioned, despite the fact that 2 of 3 Americans are now obese or overweight and obesity has been shown to be correlated with cardiac functional abnormalities. In 2000, a syndrome of "lipotoxic cardiomyopathy" resembling earlier pathologic descriptions of fatty human hearts was described in rodents, and fatty infiltration of cardiomyocytes was subsequently reported in patients with congestive failure. Now, magnetic resonance spectroscopy has been adapted to permit routine noninvasive screening for fatty heart. The use of this technique in human volunteers indicates that cardiomyocyte fat correlates well with body mass index and is elevated in uncomplicated obesity. It is more severe when glucose tolerance becomes abnormal or diabetes is present. It is associated with impaired diastolic filling, even in seemingly asymptomatic obese volunteers. Because fatty heart can be readily prevented by lifestyle modification and pharmacologic interventions that reduce caloric intake and increase fatty acid oxidation, it seems important to recognize its existence so as to intervene as early as possible.

Original languageEnglish (US)
Pages (from-to)759-767
Number of pages9
JournalCirculation Research
Volume101
Issue number8
DOIs
StatePublished - Oct 2007

Fingerprint

Cardiac Myocytes
Volunteers
Obesity
Energy Intake
Cardiomyopathies
Life Style
Rodentia
Body Mass Index
Magnetic Resonance Spectroscopy
Fatty Acids
Fats
Glucose

Keywords

  • Fatty heart
  • Lipotoxic cardiomyopathy
  • Magnetic resonance spectroscopy
  • Obesity

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Forgotten but not gone : The rediscovery of fatty heart, the most common unrecognized disease in America. / Szczepaniak, Lidia S.; Victor, Ronald G.; Orci, Lelio; Unger, Roger H.

In: Circulation Research, Vol. 101, No. 8, 10.2007, p. 759-767.

Research output: Contribution to journalArticle

Szczepaniak, Lidia S. ; Victor, Ronald G. ; Orci, Lelio ; Unger, Roger H. / Forgotten but not gone : The rediscovery of fatty heart, the most common unrecognized disease in America. In: Circulation Research. 2007 ; Vol. 101, No. 8. pp. 759-767.
@article{fc2a7d09ebb24e4984153587d0031390,
title = "Forgotten but not gone: The rediscovery of fatty heart, the most common unrecognized disease in America",
abstract = "Until 60 years ago, fatty heart was an accepted clinical entity. Since then, its very existence has been questioned, despite the fact that 2 of 3 Americans are now obese or overweight and obesity has been shown to be correlated with cardiac functional abnormalities. In 2000, a syndrome of {"}lipotoxic cardiomyopathy{"} resembling earlier pathologic descriptions of fatty human hearts was described in rodents, and fatty infiltration of cardiomyocytes was subsequently reported in patients with congestive failure. Now, magnetic resonance spectroscopy has been adapted to permit routine noninvasive screening for fatty heart. The use of this technique in human volunteers indicates that cardiomyocyte fat correlates well with body mass index and is elevated in uncomplicated obesity. It is more severe when glucose tolerance becomes abnormal or diabetes is present. It is associated with impaired diastolic filling, even in seemingly asymptomatic obese volunteers. Because fatty heart can be readily prevented by lifestyle modification and pharmacologic interventions that reduce caloric intake and increase fatty acid oxidation, it seems important to recognize its existence so as to intervene as early as possible.",
keywords = "Fatty heart, Lipotoxic cardiomyopathy, Magnetic resonance spectroscopy, Obesity",
author = "Szczepaniak, {Lidia S.} and Victor, {Ronald G.} and Lelio Orci and Unger, {Roger H}",
year = "2007",
month = "10",
doi = "10.1161/CIRCRESAHA.107.160457",
language = "English (US)",
volume = "101",
pages = "759--767",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Forgotten but not gone

T2 - The rediscovery of fatty heart, the most common unrecognized disease in America

AU - Szczepaniak, Lidia S.

AU - Victor, Ronald G.

AU - Orci, Lelio

AU - Unger, Roger H

PY - 2007/10

Y1 - 2007/10

N2 - Until 60 years ago, fatty heart was an accepted clinical entity. Since then, its very existence has been questioned, despite the fact that 2 of 3 Americans are now obese or overweight and obesity has been shown to be correlated with cardiac functional abnormalities. In 2000, a syndrome of "lipotoxic cardiomyopathy" resembling earlier pathologic descriptions of fatty human hearts was described in rodents, and fatty infiltration of cardiomyocytes was subsequently reported in patients with congestive failure. Now, magnetic resonance spectroscopy has been adapted to permit routine noninvasive screening for fatty heart. The use of this technique in human volunteers indicates that cardiomyocyte fat correlates well with body mass index and is elevated in uncomplicated obesity. It is more severe when glucose tolerance becomes abnormal or diabetes is present. It is associated with impaired diastolic filling, even in seemingly asymptomatic obese volunteers. Because fatty heart can be readily prevented by lifestyle modification and pharmacologic interventions that reduce caloric intake and increase fatty acid oxidation, it seems important to recognize its existence so as to intervene as early as possible.

AB - Until 60 years ago, fatty heart was an accepted clinical entity. Since then, its very existence has been questioned, despite the fact that 2 of 3 Americans are now obese or overweight and obesity has been shown to be correlated with cardiac functional abnormalities. In 2000, a syndrome of "lipotoxic cardiomyopathy" resembling earlier pathologic descriptions of fatty human hearts was described in rodents, and fatty infiltration of cardiomyocytes was subsequently reported in patients with congestive failure. Now, magnetic resonance spectroscopy has been adapted to permit routine noninvasive screening for fatty heart. The use of this technique in human volunteers indicates that cardiomyocyte fat correlates well with body mass index and is elevated in uncomplicated obesity. It is more severe when glucose tolerance becomes abnormal or diabetes is present. It is associated with impaired diastolic filling, even in seemingly asymptomatic obese volunteers. Because fatty heart can be readily prevented by lifestyle modification and pharmacologic interventions that reduce caloric intake and increase fatty acid oxidation, it seems important to recognize its existence so as to intervene as early as possible.

KW - Fatty heart

KW - Lipotoxic cardiomyopathy

KW - Magnetic resonance spectroscopy

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=35448950503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448950503&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.107.160457

DO - 10.1161/CIRCRESAHA.107.160457

M3 - Article

C2 - 17932333

AN - SCOPUS:35448950503

VL - 101

SP - 759

EP - 767

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 8

ER -